NYSE:SNN
Smith & Nephew SNATS Inc Stock News
$24.78
+0.340 (+1.39%)
At Close: May 03, 2024
Smith & Nephew's (SNN) CIT Technology Favored by New Study
09:12am, Friday, 24'th Mar 2023
Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.
Smith & Nephew (SNN) Simplifies ACL Surgery With New Offers
09:11am, Thursday, 09'th Mar 2023
Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.
What Makes Smith & Nephew (SNN) a New Buy Stock
01:33pm, Thursday, 23'rd Feb 2023
Smith & Nephew (SNN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Smith & Nephew: Orthopedic Franchise Finally Coming Along
11:15am, Wednesday, 22'nd Feb 2023
Company reports top-line growth in Q4. Innovation & operational leverage finally turning the screw here.
Smith & Nephew plc (SNN) Q4 2022 Earnings Call Transcript
09:50pm, Tuesday, 21'st Feb 2023
Smith & Nephew plc (NYSE:SNN ) Q4 2022 Earnings Conference Call February 21, 2023 3:30 AM ET Company Participants Deepak Nath - CEO Anne-Francoise Nesmes - CFO Conference Call Participants Jack Reynol
Smith & Nephew annual profits fall as margins take a hit
02:57am, Tuesday, 21'st Feb 2023
Smith & Nephew PLC (LSE:SN) reported flat annual revenue but declining margins meant operating profit fell sharply. The global medical technology company said operating profit margins slipped to 8.6%
Smith & Nephew Is Reverting to Fair Value
04:04pm, Wednesday, 25'th Jan 2023
The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging
Smith & Nephew plc (SNN) Q3 2022 Earnings Call Transcript
05:13pm, Saturday, 05'th Nov 2022
Smith & Nephew plc (NYSE:SNN ) Q3 2022 Results Conference Call November 3, 2022 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Co
Smith & Nephew says 'on track' to meet full-year revenue forecast
03:56am, Thursday, 03'rd Nov 2022
Smith & Nephew PLC (LSE:SN) reported a 4.8% increase in underlying revenue for the third quarter and forecast revenue growth for the full year in the middle of its previously guided range of 4%-5%.
Smith & Nephew little boosted by rivals' reports of improving hip and knee sales
04:20am, Friday, 21'st Oct 2022
Smith & Nephew PLC (LSE:SN) shares reacted to reports from US medical technology companies that surgical procedure volumes are returning to pre-pandemic levels.
Smith & Nephew: Still A Buy Despite Short-Term Challenges
08:21am, Monday, 26'th Sep 2022
Medical devices manufacturer Smith & Nephew (S&N) has seen its shares sliding. I do not yet see the growth the company is targeting, but business has been recovering and its interim figures were decen
Smith & Nephew: A Medical Equipment Opportunity
04:54pm, Tuesday, 09'th Aug 2022
FTSE 100 constituent and medical equipment maker Smith & Nephew PLC ( SNN , Financial) ( LSE:SN. , Financial) seemed to be making progress after its 2021 results in February.
Smith & Nephew plc (SNN) CEO Deepak Nath on Q2 2022 Results - Earnings Call Transcript
06:04pm, Friday, 29'th Jul 2022
Smith & Nephew plc (NYSE:SNN ) Q2 2022 Results Conference Call July 28, 2022 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Confe
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
04:41pm, Thursday, 28'th Jul 2022 Benzinga
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con